Home LiteratureArticle Details
PMID: 15175328 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2.

The Journal of biological chemistry ·Vol. 279 ·No. 32 ·2004-08-06 ·Pages 33185-91

Lee TH, Shank J, Cusson N, Kelliher MA

Abstract

The death domain kinase Rip1 is recruited to the tumor necrosis factor receptor type 1 and mediates the IkappaB kinase and p38 MAP kinase pathways. In response to tumor necrosis factor-alpha (TNF-alpha), we find Rip1 phosphorylated and ubiquitinated, suggesting that Rip1 phosphorylation may stimulate its ubiquitination. To address the contribution of the kinase activity of Rip1 to its ubiquitination and to TNF-alpha signaling, we introduced wild type Rip1 and a kinase-inactive form of Rip1, Rip1D138N, into rip1-/- murine embryonic fibroblast cells by retroviral infection. TNF-alpha-induced ubiquitination of Rip1 is observed in Rip1D138N cells, supporting the argument that Rip1 autophosphorylation is not required for Rip1 ubiquitination. TNF-alpha-induced Ikk and p38 MAP kinase activation is normal, and the Rip1D138N cells are resistant to TNF-alpha-induced cell death, indicating that the kinase activity of Rip1 is not required to mediate its antiapoptotic functions. In the absence of Traf2, TNF-alpha-induced ubiquitination of Rip1 is impaired, suggesting that Traf2 may be the E3 ubiquitin ligase responsible for the TNF-alpha-dependent, ubiquitination of Rip1. Finally, recruitment of the ubiquitinated Tak1 complex is dependent on the presence of Rip1, suggesting that Rip1 ubiquitination rather than its phosphorylation is critical in signaling.

MeSH Terms
Animals Antigens, CD/metabolism Apoptosis/drug effects Embryo, Mammalian Enzyme Activation/drug effects Fibroblasts GTPase-Activating Proteins/deficiency,physiology I-kappa B Kinase Interleukin-6/biosynthesis MAP Kinase Kinase Kinases/metabolism Mice Mice, Knockout Mitogen-Activated Protein Kinases/metabolism NF-kappa B/metabolism Phosphorylation Protein Processing, Post-Translational Protein Serine-Threonine Kinases/metabolism Proteins/metabolism Receptors, Tumor Necrosis Factor/metabolism Receptors, Tumor Necrosis Factor, Type I TNF Receptor-Associated Factor 2 Transfection Tumor Necrosis Factor-alpha/pharmacology Ubiquitin/metabolism p38 Mitogen-Activated Protein Kinases
Chemicals
Antigens, CD GTPase-Activating Proteins Interleukin-6 NF-kappa B Proteins Ralbp1 protein, mouse Receptors, Tumor Necrosis Factor Receptors, Tumor Necrosis Factor, Type I TNF Receptor-Associated Factor 2 Tumor Necrosis Factor-alpha Ubiquitin Protein Serine-Threonine Kinases Chuk protein, mouse I-kappa B Kinase Ikbkb protein, mouse Ikbke protein, mouse Mitogen-Activated Protein Kinases p38 Mitogen-Activated Protein Kinases MAP Kinase Kinase Kinases MAP kinase kinase kinase 7
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lee Thomas H
Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
Shank Jennifer
Cusson Nicole
Kelliher Michelle A
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2004-08-06
Epub
2004-00-01
Pages
33185-91
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NIGMS NIH HHS · R01 GM061298 · United States
NIGMS NIH HHS · GM61298 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com